Exact Sciences announced Thursday that Cologuard, the first FDA-approved non-invasive screening test for colorectal cancer and precancer, will be covered by The Centers for Medicare & Medicaid Services (CMS). “We are…

Exact Sciences‘ Cologuard, which received its FDA approval last month, will be offered to Group Health Cooperative patients, the organization announced recently. GHC will be the first health plan in Wisconsin to…

A major milestone for Exact Sciences was achieved Monday, when the company announced its colorectal cancer screening test called Cologuard received approval from the U.S. Food and Drug Administration (FDA). “The FDA…

Former Wisconsin Gov. Jim Doyle was elected to the Exact Sciences board of directors, the company announced recently. Doyle, who currently works with both Foley & Lardner and his own company,…

A preliminary examination of Exact Sciences‘ Cologuard colorectal cancer screening test showed promising data for detection of colorectal cancer and pre-cancerous polyps, the company announced recently. “There is a significant unmet clinical…